Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 711

1.

Decreased telomere length in the small airway epithelium suggests accelerated aging in the lungs of persons living with human immunodeficiency virus (HIV).

Xu S, Vucic EA, Shaipanich T, Lam S, Lam W, Montaner JS, Sin DD, Paul Man SF, Leung JM.

Respir Res. 2018 Jun 13;19(1):117. doi: 10.1186/s12931-018-0821-0.

2.

2018 update to the HIV-TRePS system: the development of new computational models to predict HIV treatment outcomes, with or without a genotype, with enhanced usability for low-income settings.

Revell AD, Wang D, Perez-Elias MJ, Wood R, Cogill D, Tempelman H, Hamers RL, Reiss P, van Sighem AI, Rehm CA, Pozniak A, Montaner JSG, Lane HC, Larder BA; RDI Data and Study Group .

J Antimicrob Chemother. 2018 Jun 8. doi: 10.1093/jac/dky179. [Epub ahead of print]

PMID:
29889249
3.

Nationwide cohort study of antiretroviral therapy timing: treatment dropout and virological failure in China, 2011-2015.

Zhao Y, Wu Z, McGoogan JM, Sha Y, Zhao D, Ma Y, Brookmeyer R, Detels R, Montaner JSG.

Clin Infect Dis. 2018 May 16. doi: 10.1093/cid/ciy400. [Epub ahead of print]

PMID:
29771296
4.

The impact of HCV co-infection status on healthcare-related utilization among people living with HIV in British Columbia, Canada: a retrospective cohort study.

Ma H, Villalobos CF, St-Jean M, Eyawo O, Lavergne MR, Ti L, Hull MW, Yip B, Wu L, Hogg RS, Barrios R, Shoveller JA, Montaner JSG, Lima VD.

BMC Health Serv Res. 2018 May 2;18(1):319. doi: 10.1186/s12913-018-3119-5.

5.

Adverse drug reactions to integrase strand transfer inhibitors.

Lepik KJ, Yip B, Ulloa AC, Wang L, Toy J, Akagi L, Lima VD, Guillemi S, Montaner JSG, Barrios R.

AIDS. 2018 Apr 24;32(7):903-912. doi: 10.1097/QAD.0000000000001781.

PMID:
29424784
6.

Social and structural factors associated with greater time with a plasma HIV-1 RNA viral load above log10(1500) copies/ml among illicit drug users.

Kennedy MC, Kerr TH, Wood E, Shoveller JA, Montaner JSG, Milloy MS.

AIDS. 2018 May 15;32(8):1059-1067. doi: 10.1097/QAD.0000000000001777.

PMID:
29424782
7.

Mortality among people living with HIV/AIDS with non-small-cell lung cancer in the modern HAART Era.

Smith DM, Salters KA, Eyawo O, Franco-Villalobos C, Jabbari S, Wiseman SM, Press N, Montaner JSG, Man SFP, Hull M, Hogg RS.

AIDS Care. 2018 Jul;30(7):936-942. doi: 10.1080/09540121.2018.1434120. Epub 2018 Feb 7.

PMID:
29411625
8.

Trends in discharges from the HIV/AIDS ward at a tertiary Canadian Hospital from 2005 to 2014.

Jaworsky D, Phillips P, Cui Z, Chau W, Colley G, Dutta R, Yip B, Kremer H, Eyawo O, Montaner JS, Hull MW.

AIDS Care. 2018 Feb 4:1-8. doi: 10.1080/09540121.2018.1434121. [Epub ahead of print]

PMID:
29397766
9.

Trends in Awareness and Use of HIV PrEP Among Gay, Bisexual, and Other Men who have Sex with Men in Vancouver, Canada 2012-2016.

Mosley T, Khaketla M, Armstrong HL, Cui Z, Sereda P, Lachowsky NJ, Hull MW, Olarewaju G, Jollimore J, Edward J, Montaner JSG, Hogg RS, Roth EA, Moore DM.

AIDS Behav. 2018 Jan 17. doi: 10.1007/s10461-018-2026-4. [Epub ahead of print]

PMID:
29344740
10.

Cohort profile: the Comparative Outcomes And Service Utilization Trends (COAST) Study among people living with and without HIV in British Columbia, Canada.

Eyawo O, Hull MW, Salters K, Samji H, Cescon A, Sereda P, Lima VD, Nosyk B, Whitehurst DGT, Lear SA, Montaner JSG, Hogg RS; Comparative Outcomes And Service Utilization Trends (COAST) Study.

BMJ Open. 2018 Jan 13;8(1):e019115. doi: 10.1136/bmjopen-2017-019115.

11.

Declining Mortality Rates in HIV-Infected People Who Inject Drugs During a Seek-and-Treat Initiative in Vancouver, Canada, 1996-2014: A Prospective Cohort Study.

Hayashi K, Dong H, Kerr T, Dobrer S, Guillemi S, Barrios R, Montaner JSG, Wood E, Milloy MJ.

J Infect Dis. 2017 Dec 27;217(1):64-68. doi: 10.1093/infdis/jix459.

PMID:
29240903
12.

Incidence of diabetes mellitus and factors associated with its development in HIV-positive patients over the age of 50.

Samad F, Harris M, Puskas CM, Ye M, Chia J, Chacko S, Bondy GP, Lima VD, Montaner JS, Guillemi SA.

BMJ Open Diabetes Res Care. 2017 Nov 26;5(1):e000457. doi: 10.1136/bmjdrc-2017-000457. eCollection 2017.

13.

Progress towards the United Nations 90-90-90 and 95-95-95 targets: the experience in British Columbia, Canada.

Lima VD, St-Jean M, Rozada I, Shoveller JA, Nosyk B, Hogg RS, Sereda P, Barrios R, Montaner JSG.

J Int AIDS Soc. 2017 Nov;20(3). doi: 10.1002/jia2.25011.

14.

HIV treatment simplification to elvitegravir/cobicistat/emtricitabine/tenofovir disproxil fumarate (E/C/F/TDF) plus darunavir: a pharmacokinetic study.

Harris M, Ganase B, Watson B, Harrigan PR, Montaner JSG, Hull MW.

AIDS Res Ther. 2017 Nov 2;14(1):59. doi: 10.1186/s12981-017-0185-4.

15.

Immediate Antiretroviral Therapy Decreases Mortality Among Patients With High CD4 Counts in China: A Nationwide, Retrospective Cohort Study.

Zhao Y, Wu Z, McGoogan JM, Shi CX, Li A, Dou Z, Ma Y, Qin Q, Brookmeyer R, Detels R, Montaner JSG.

Clin Infect Dis. 2018 Feb 10;66(5):727-734. doi: 10.1093/cid/cix878.

16.

Characterizing Human Immunodeficiency Virus Antiretroviral Therapy Interruption and Resulting Disease Progression Using Population-Level Data in British Columbia, 1996-2015.

Wang L, Min JE, Zang X, Sereda P, Harrigan RP, Montaner JSG, Nosyk B.

Clin Infect Dis. 2017 Oct 16;65(9):1496-1503. doi: 10.1093/cid/cix570.

PMID:
29048508
17.

The Cost-Effectiveness of Human Immunodeficiency Virus Testing and Treatment Engagement Initiatives in British Columbia, Canada: 2011-2013.

Nosyk B, Min JE, Krebs E, Zang X, Compton M, Gustafson R, Barrios R, Montaner JSG; STOP HIV/AIDS Study Group .

Clin Infect Dis. 2018 Feb 10;66(5):765-777. doi: 10.1093/cid/cix832.

PMID:
29028964
18.

Belief in Treatment as Prevention and Its Relationship to HIV Status and Behavioral Risk.

Card KG, Armstrong HL, Lachowsky NJ, Cui Z, Sereda P, Carter A, Montaner JSG, Hogg RS, Roth EA, Moore DM.

J Acquir Immune Defic Syndr. 2018 Jan 1;77(1):8-16. doi: 10.1097/QAI.0000000000001557.

PMID:
28991882
19.

A historical review of HIV prevention and care initiatives in British Columbia, Canada: 1996-2015.

Olding M, Enns B, Panagiotoglou D, Shoveller J, Harrigan PR, Barrios R, Kerr T, Montaner JSG, Nosyk B.

J Int AIDS Soc. 2017 Sep 19;20(1):21941. doi: 10.7448/IAS.20.1.21941. Review.

20.

The effect of socioeconomic disadvantage on strategies to end the AIDS epidemic.

Hogg RS, Puskas C, Parashar S, Montaner JSG.

Lancet Public Health. 2016 Nov;1(1):e6-e7. doi: 10.1016/S2468-2667(16)30007-X. Epub 2016 Oct 12. No abstract available.

21.

Testing and linkage to HIV care in China: a cluster-randomised trial.

Wu Z, Tang Z, Mao Y, Van Veldhuisen P, Ling W, Liu D, Shen Z, Detels R, Lan G, Erinoff L, Lindblad R, Gu D, Tang H, Hu L, Zhu Q, Lu L, Oden N, Hasson AL, Zhao Y, McGoogan JM, Ge X, Zhang N, Rou K, Zhu J, Wei H, Shi CX, Jin X, Li J, Montaner JSG.

Lancet HIV. 2017 Dec;4(12):e555-e565. doi: 10.1016/S2352-3018(17)30131-5. Epub 2017 Aug 31.

PMID:
28867267
22.

Association between public injecting and drug-related harm among HIV-positive people who use injection drugs in a Canadian setting: A longitudinal analysis.

Ickowicz S, Wood E, Dong H, Nguyen P, Small W, Kerr T, Montaner JSG, Milloy MJ.

Drug Alcohol Depend. 2017 Nov 1;180:33-38. doi: 10.1016/j.drugalcdep.2017.07.016. Epub 2017 Aug 10.

PMID:
28865390
23.

Factors associated with low neighborhood cohesion among women living with HIV impacted by social-structural inequities in British Columbia.

Closson K, Palmer AK, Collins AB, Salters K, Zhang W, Montaner JSG, Hogg RS, Parashar S.

AIDS Care. 2018 Mar;30(3):318-324. doi: 10.1080/09540121.2017.1363368. Epub 2017 Aug 17.

PMID:
28814104
24.

Erratum to: Factors Associated with Mood Disorder Diagnosis Among a Population Based Cohort of Men and Women Living With and Without HIV in British Columbia Between 1998 and 2012.

Closson K, Osborne C, Smith DM, Kesselring S, Eyawo O, Card K, Sereda P, Jabbari S, Franco-Villalobos C, Ahmed T, Gabler K, Patterson T, Hull M, Montaner JSG, Hogg RS; Comparative Outcomes and Services utilization Trends (COAST) study.

AIDS Behav. 2018 May;22(5):1541. doi: 10.1007/s10461-017-1858-7. No abstract available.

PMID:
28741132
25.

Drug use and phylogenetic clustering of hepatitis C virus infection among people who use drugs in Vancouver, Canada: A latent class analysis approach.

Jacka B, Bray BC, Applegate TL, Marshall BDL, Lima VD, Hayashi K, DeBeck K, Raghwani J, Harrigan PR, Krajden M, Montaner JSG, Grebely J Senior.

J Viral Hepat. 2018 Jan;25(1):28-36. doi: 10.1111/jvh.12758. Epub 2017 Sep 4.

PMID:
28719060
26.

Informing Targeted Interventions to Optimize the Cascade of HIV Care Using Cluster Analyses of Health Resource Use Among People Living with HIV/AIDS.

Krebs E, Min JE, Bayoumi AM, Barrios R, Montaner JSG, Nosyk B; STOP HIV/AIDS Study Group.

AIDS Behav. 2018 Jan;22(1):234-244. doi: 10.1007/s10461-017-1839-x.

PMID:
28660380
27.

Increased mortality among Indigenous persons in a multisite cohort of people living with HIV in Canada.

Benoit AC, Younger J, Beaver K, Jackson R, Loutfy M, Masching R, Nobis T, Nowgesic E, O'Brien-Teengs D, Whitebird W, Zoccole A, Hull M, Jaworsky D, Benson E, Rachlis A, Rourke SB, Burchell AN, Cooper C, Hogg RS, Klein MB, Machouf N, Montaner JSG, Tsoukas C, Raboud J.

Can J Public Health. 2017 Jun 16;108(2):e169-e175. doi: 10.17269/cjph.108.5708.

PMID:
28621653
28.

Factors Associated with Mood Disorder Diagnosis Among a Population Based Cohort of Men and Women Living With and Without HIV in British Columbia Between 1998 and 2012.

Closson K, Osborne C, Smith DM, Kesselring S, Eyawo O, Card K, Sereda P, Jabbari S, Franco-Villalobos C, Ahmed T, Gabler K, Patterson T, Hull M, Montaner JSG, Hogg RS; Comparative Outcomes and Services utilization Trends (COAST) study.

AIDS Behav. 2018 May;22(5):1530-1540. doi: 10.1007/s10461-017-1825-3. Erratum in: AIDS Behav. 2017 Jul 24;:.

PMID:
28612214
29.

Care cascade structural intervention versus standard of care in the diagnosis and treatment of HIV in China: a cluster-randomized controlled trial protocol.

Mao Y, Wu Z, McGoogan JM, Liu D, Gu D, Erinoff L, Ling W, VanVeldhuisen P, Detels R, Hasson AL, Lindblad R, Montaner JSG, Tang Z, Zhao Y.

BMC Health Serv Res. 2017 Jun 12;17(1):397. doi: 10.1186/s12913-017-2323-z.

30.

Initiating HCV treatment with direct acting agents in opioid agonist treatment: When to start for people co-infected with HIV?

Panagiotoglou D, Krebs E, Min JE, Olding M, Ahamad K, Ti L, Montaner JSG, Nosyk B.

Int J Drug Policy. 2017 Sep;47:169-176. doi: 10.1016/j.drugpo.2017.05.021. Epub 2017 Jun 1.

PMID:
28578865
31.

HIV and the criminalisation of drug use among people who inject drugs: a systematic review.

DeBeck K, Cheng T, Montaner JS, Beyrer C, Elliott R, Sherman S, Wood E, Baral S.

Lancet HIV. 2017 Aug;4(8):e357-e374. doi: 10.1016/S2352-3018(17)30073-5. Epub 2017 May 14. Review.

PMID:
28515014
32.

Is there a rural/urban gap in the quality of HIV care for treatment-naïve HIV-positive individuals initiating antiretroviral therapy in British Columbia?

MacKenzie LJ, Hull MW, Samji H, Lima VD, Yip B, Zhang W, Lourenço L, Colley G, Hogg RS, Montaner JSG.

AIDS Care. 2017 Oct;29(10):1218-1226. doi: 10.1080/09540121.2017.1322678. Epub 2017 May 4.

PMID:
28472896
33.

Overview of cancer incidence and mortality among people living with HIV/AIDS in British Columbia, Canada: Implications for HAART use and NADM development.

Chiu CG, Smith D, Salters KA, Zhang W, Kanters S, Milan D, Montaner JSG, Coldman A, Hogg RS, Wiseman SM.

BMC Cancer. 2017 Apr 14;17(1):270. doi: 10.1186/s12885-017-3229-1.

34.

Comparison of atazanavir/ritonavir and darunavir/ritonavir based antiretroviral therapy for antiretroviral naïve patients.

Antoniou T, Szadkowski L, Walmsley S, Cooper C, Burchell AN, Bayoumi AM, Montaner JS, Loutfy M, Klein MB, Machouf N, Tsoukas C, Wong A, Hogg RS, Raboud J; Canadian Observational Cohort (CANOC) collaboration.

BMC Infect Dis. 2017 Apr 11;17(1):266. doi: 10.1186/s12879-017-2379-8.

35.

Lifetime Doctor-Diagnosed Mental Health Conditions and Current Substance Use Among Gay and Bisexual Men Living in Vancouver, Canada.

Lachowsky NJ, Dulai JJ, Cui Z, Sereda P, Rich A, Patterson TL, Corneil TT, Montaner JS, Roth EA, Hogg RS, Moore DM.

Subst Use Misuse. 2017 May 12;52(6):785-797. doi: 10.1080/10826084.2016.1264965. Epub 2017 Feb 7.

36.

Emergent drug resistance with integrase strand transfer inhibitor-based regimens.

Lepik KJ, Harrigan PR, Yip B, Wang L, Robbins MA, Zhang WW, Toy J, Akagi L, Lima VD, Guillemi S, Montaner JSG, Barrios R.

AIDS. 2017 Jun 19;31(10):1425-1434. doi: 10.1097/QAD.0000000000001494.

PMID:
28375875
37.

Relative effects of antiretroviral therapy and harm reduction initiatives on HIV incidence in British Columbia, Canada, 1996-2013: a modelling study.

Nosyk B, Zang X, Min JE, Krebs E, Lima VD, Milloy MJ, Shoveller J, Barrios R, Harrigan PR, Kerr T, Wood E, Montaner JSG.

Lancet HIV. 2017 Jul;4(7):e303-e310. doi: 10.1016/S2352-3018(17)30045-0. Epub 2017 Mar 30.

38.

The adherence gap: a longitudinal examination of men's and women's antiretroviral therapy adherence in British Columbia, 2000-2014.

Puskas CM, Kaida A, Miller CL, Zhang W, Yip B, Pick N, Montaner JS, Hogg RS.

AIDS. 2017 Mar 27;31(6):827-833. doi: 10.1097/QAD.0000000000001408.

PMID:
28272135
39.

Health-adjusted life expectancy in HIV-positive and HIV-negative men and women in British Columbia, Canada: a population-based observational cohort study.

Hogg RS, Eyawo O, Collins AB, Zhang W, Jabbari S, Hull MW, Lima VD, Ahmed T, Kendall CE, Althoff KN, Justice AC, Barrios R, Shoveller J, Montaner JSG; Comparative Outcomes And Service Utilization Trends (COAST) study.

Lancet HIV. 2017 Jun;4(6):e270-e276. doi: 10.1016/S2352-3018(17)30029-2. Epub 2017 Mar 3.

40.

Changes in mortality rates and causes of death in a population-based cohort of persons living with and without HIV from 1996 to 2012.

Eyawo O, Franco-Villalobos C, Hull MW, Nohpal A, Samji H, Sereda P, Lima VD, Shoveller J, Moore D, Montaner JS, Hogg RS; Comparative Outcomes And Service Utilization Trends (COAST) study.

BMC Infect Dis. 2017 Feb 27;17(1):174. doi: 10.1186/s12879-017-2254-7.

41.

Increases in CD4+ T-cell count at antiretroviral therapy initiation among HIV-positive illicit drug users during a treatment-as-prevention initiative in Canada.

Tran M, Wood E, Kerr T, Patterson S, Bangsberg D, Dong H, Guillemi S, Montaner JS, Milloy MJ.

Antivir Ther. 2017;22(5):403-411. doi: 10.3851/IMP3145. Epub 2017 Feb 24.

42.

The Hotel Study-Clinical and Health Service Effectiveness in a Cohort of Homeless or Marginally Housed Persons.

Honer WG, Cervantes-Larios A, Jones AA, Vila-Rodriguez F, Montaner JS, Tran H, Nham J, Panenka WJ, Lang DJ, Thornton AE, Vertinsky T, Barr AM, Procyshyn RM, Smith GN, Buchanan T, Krajden M, Krausz M, MacEwan GW, Gicas KM, Leonova O, Langheimer V, Rauscher A, Schultz K.

Can J Psychiatry. 2017 Jul;62(7):482-492. doi: 10.1177/0706743717693781. Epub 2017 Feb 15.

43.

Estimation of measurement error in plasma HIV-1 RNA assays near their limit of quantification.

Lima VD, Wang L, Brumme C, Wu L, Montaner JS, Harrigan PR.

PLoS One. 2017 Feb 2;12(2):e0171155. doi: 10.1371/journal.pone.0171155. eCollection 2017.

44.

Rates and predictors of injury in a population-based cohort of people living with HIV.

Samji H, Zhang W, Eyawo O, Jabbari S, Colley G, Tanner Z, Hull M, Montaner JS, Hogg RS; COAST Study Team.

AIDS. 2017 Jan 14;31(2):295-304. doi: 10.1097/QAD.0000000000001328.

PMID:
28002085
45.

Cost-Effectiveness of the 'One4All' HIV Linkage Intervention in Guangxi Zhuang Autonomous Region, China.

Zang X, Tang H, Min JE, Gu D, Montaner JS, Wu Z, Nosyk B.

PLoS One. 2016 Nov 28;11(11):e0167308. doi: 10.1371/journal.pone.0167308. eCollection 2016.

46.

A Multi-State Model Examining Patterns of Transitioning Among States of Engagement in Care in HIV-Positive Individuals Initiating Combination Antiretroviral Therapy.

Gillis J, Loutfy M, Bayoumi AM, Antoniou T, Burchell AN, Walmsley S, Cooper C, Klein MB, Machouf N, Montaner JS, Rourke SB, Tsoukas C, Hogg R, Raboud J; CANOC Collaboration.

J Acquir Immune Defic Syndr. 2016 Dec 15;73(5):531-539.

47.

An Event-Level Analysis of Condom Use During Anal Intercourse Among Self-Reported Human Immunodeficiency Virus-Negative Gay and Bisexual Men in a Treatment as Prevention Environment.

Lachowsky NJ, Tanner Z, Cui Z, Sereda P, Rich A, Jollimore J, Montaner JS, Hogg RS, Moore DM, Roth EA.

Sex Transm Dis. 2016 Dec;43(12):765-770.

48.

The bronchial epithelial cell bacterial microbiome and host response in patients infected with human immunodeficiency virus.

Sze MA, Xu S, Leung JM, Vucic EA, Shaipanich T, Moghadam A, Harris M, Guillemi S, Sinha S, Nislow C, Murphy D, Hague C, Leipsic J, Lam S, Lam W, Montaner JS, Sin DD, Man SF.

BMC Pulm Med. 2016 Nov 9;16(1):142.

49.

Use of injectable hormonal contraception and HSV-2 acquisition in a cohort of female sex workers in Vancouver, Canada.

Socías ME, Duff P, Shoveller J, Montaner JSG, Nguyen P, Ogilvie G, Shannon K.

Sex Transm Infect. 2017 Jun;93(4):284-289. doi: 10.1136/sextrans-2016-052838. Epub 2016 Nov 7.

50.

Achieving the 90-90-90 target: incentives for HIV testing.

Wainberg MA, Hull MW, Girard PM, Montaner JSG.

Lancet Infect Dis. 2016 Nov;16(11):1215-1216. doi: 10.1016/S1473-3099(16)30383-8. No abstract available.

PMID:
27788971

Supplemental Content

Loading ...
Support Center